✦ LIBER ✦

Cost-Effectiveness Of Prophylaxis Of Respiratory Syncytial Virus Infection (RSV) With Palivizumab In Preterm Infants In Colombia

✍ Scribed by Rosselli, D.; Rueda, J.D.; Ruiz, J.G.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cost-effectiveness analysis of palivizum

✍ Kristian Neovius; Katharina Buesch; Kristina Sandström; Martin Neovius 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 354 KB

PIN36 COST-EFFECTIVENESS OF RESPIRATORY

✍ E Kowalik; MK Jakubczyk; MP Niewada; B Kamiñski 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 84 KB

Cost-effectiveness of respiratory syncyt

✍ Carole A Reeve; John S Whitehall; Petra G Buettner; Robert Norton; David M Reeve 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 75 KB

Cost-Effectiveness Analysis of Palivizum

✍ Langenfeld, M.K.; Visser, S. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB

Palivizumab for respiratory syncytial vi

✍ Jennifer H. Lofland; Suzanne M. Touch; John P. O'Connor; Mary Lou Chatterton; El 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 890 KB

Palivizumab in the prophylaxis of respir

✍ Cardenas, Silvia ;Auais, Alexander ;Piedimonte, Giovanni 📂 Article 📅 2005 🏛 Expert Reviews 🌐 English ⚖ 148 KB